Home » Newsletters » BioWorld Science

BioWorld Science

July 31, 1997

View Archived Issues

Epitope reacquires marketing rights from SmithKline Beecham for oral HIV diagnostic

Cell adhesion inhibitors disclosed by Hoechst

Novel immunomodulating agents from Gruenenthal

HMR discovers elastase inhibitors and prodrugs thereof

Agents for Parkinson's disease prepared at Rhone-Poulenc Rorer

New oral carbapenems with enhanced antibacterial activity

Antimicrobial DHFR inhibitors from Roche

Potential antitumor agents evaluated by Taiwan researchers

Osteoporosis test from Cortecs nearing launch

Antiobesity drug therapy

Clinical pharmacokinetics, safety and efficacy of orlistat

Phase I comparison of CCKA agonist and CCK-8 for effects on satiety

Caelyx approved in Australia and New Zealand

Acute and subchronic effects of SR-58611A on glucose tolerance in mice

Troglitazone approved in the U.K.

Korean researchers describe new cephalosporins

AEterna reports promising safety profile for Neovastat

Japanese investigators present agents for restenosis

Topical antiinflammatory steroids devoid of glucocorticoid-like side effects

Potent calpain inhibitor discovered at Senju

Clinical trial of Lipitor for the reduction of cholesterol in women

U.S. Bioscience: Q2 1997 highlights

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...